Amy Kruse - Partner & Principal Biologist @ Prime Movers Lab

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

67,938

Primary Job Title Partner & Principal Biologist
Primary Organization
Prime Movers Lab

Location Washington, District of Columbia, United States
Regions Washington DC Metro Area, Southern US
Gender Female

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Amy Kruse currently works as the partner and principal biologist for Prime Movers Lab. She previously worked at Optios as the chief scientific officer.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Gilgamesh Pharmaceuticals	Satori Capital	Yes	Series A - Gilgamesh Pharmaceuticals	obfuscated obfuscation
obfuscated obfuscation	NextSense	Satori Capital	—	Series A - NextSense	obfuscated obfuscation
obfuscated obfuscation	Feel Therapeutics	Satori Capital	—	Convertible Note - Feel Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Motif Neurotech	Satori Capital	—	Series A - Motif Neurotech	obfuscated obfuscation
obfuscated obfuscation	TARA Mind	Satori Capital	Yes	Seed Round - TARA Mind	obfuscated obfuscation
obfuscated obfuscation	Dimension Inx	Prime Movers Lab	Yes	Series A - Dimension Inx	obfuscated obfuscation
obfuscated obfuscation	Morphoceuticals	Prime Movers Lab	Yes	Seed Round - Morphoceuticals	obfuscated obfuscation
obfuscated obfuscation	Gilgamesh Pharmaceuticals	Prime Movers Lab	Yes	Series B - Gilgamesh Pharmaceuticals	obfuscated obfuscation
obfuscated obfuscation	Cognixion	Prime Movers Lab	Yes	Seed Round - Cognixion	obfuscated obfuscation
obfuscated obfuscation	Iridia	Prime Movers Lab	Yes	Series B - Iridia	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Amy Kruse

is the

Partner & Principal Biologist

Prime Movers Lab

. Additionally,

Amy Kruse

has had

past jobs including

Chief Scientific Officer

Optios

Prime Movers Lab Partner & Principal BiologistNov 2020

Organization Name	Title At Company	Start Date	End Date
Optios	Chief Scientific Officer	Feb 2017	Jun 2020
Cubic Corporation	Chief Technology Officer	Sep 2015	Feb 2017

Board and Advisor Roles

Number of Current Board & Advisor Roles

Amy Kruse

holds

board and advisor roles including

Board Member

Feel Therapeutics

Board Member

Morphoceuticals

, and

Board Member

Dimension Inx

Feel Therapeutics Board MemberJan 9, 2024
Morphoceuticals Board MemberFeb 15, 2023
Dimension Inx Board MemberFeb 1, 2023
Gilgamesh Pharmaceuticals Board MemberApr 2021
Paradromics Board Member
Motif Neurotech Board Member

Related Hubs

Hub Name	CB Rank (Hub)
Venture Capital Companies With Less Than $50M in Revenue	8,545
Venture Capital Companies With Less Than $500M in Revenue	8,158
Finance Companies With More Than $1M in Revenue (Top 10K)	2,412
Life Science Companies With More Than 10 Employees	8,935
United States Seed Stage Companies With Less Than $1B in Revenue (Top 10K)	4,980
Venture Stage Investors with Investments in Washington DC Metro Area	13,873
Seed Stage Investors with Investments in Washington, District of Columbia	17,410
Venture Capital Companies With Less Than $1B in Revenue	7,988
Venture Capital Companies with Seed Funding	55,407
United States Seed Stage Companies With More Than 10 Employees (Top 10K)	5,466